List of medicinal products under additional monitoring

List of medicinal products under additional monitoring

Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 13, Status: Authorised

Joint HMA/EMA Big Data Steering Group workshop on RWE methods, Online, European Medicines Agency, Amsterdam, the Netherlands, 14 June 2024

Agenda - Joint HMA/EMA Big Data Steering Group Workshop on RWE methods

List of medicines under additional monitoring

Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Posaconazole AHCL, posaconazole, Date of authorisation: 25/07/2019, Revision: 7, Status: Authorised

Information and Q&A session on updated CAPs in web-based eAF, Online, European Medicines Agency, Amsterdam, the Netherlands, from 7 May 2024, 10:00 (CEST) to 7 May 2024, 11:00 (CEST)

Human medicines European public assessment report (EPAR): Posaconazole Accord, posaconazole, Date of authorisation: 25/07/2019, Revision: 9, Status: Authorised